©The Author(s) 2023.
World J Gastrointest Oncol. Apr 15, 2023; 15(4): 571-595
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.571
Published online Apr 15, 2023. doi: 10.4251/wjgo.v15.i4.571
Table 1 Molecular targets for pancreatic cancer treatment
| Target | Frequency of mutation/expression, % |
| KRAS | 95 |
| VEGF | 93 |
| Sonic hedgehog | 70 |
| Notch3 | 69-74 |
| TP53 | 70 |
| NF-kB | 70 |
| IGF-1R | 64 |
| CDKN2A | 60 |
| EGFR | 43-69 |
| Akt/mTOR | 40 |
| SMAD | 40 |
| BRCA1/2 | 1-3 |
| NRG1 fusion | 0.5 |
| NTRK fusion | 0.3 |
- Citation: Fang YT, Yang WW, Niu YR, Sun YK. Recent advances in targeted therapy for pancreatic adenocarcinoma. World J Gastrointest Oncol 2023; 15(4): 571-595
- URL: https://www.wjgnet.com/1948-5204/full/v15/i4/571.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i4.571